focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,096.00
Bid: 11,850.00
Ask: 12,400.00
Change: 0.00 (0.00%)
Spread: 550.00 (4.641%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,096.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Ireland sees strong early evidence that vaccines are working

Thu, 25th Feb 2021 19:03

By Padraic Halpin

DUBLIN, Feb 25 (Reuters) - Ireland is beginning to see
strong early evidence that its COVID-19 vaccine rollout is
protecting healthcare workers and care home residents from
catching the disease, health officials said on Thursday.

Ireland has administered almost 360,000 vaccines among its
population of 4.9 million, so far to healthcare workers, care
home residents and most recently people aged over 85. Just over
133,000 of those have received the second of their two doses.

The officials pointed to a sharp fall in the number of
healthcare workers contracting COVID-19 to below 300 last week
from almost 1,400 in the final week in January.

Ireland is mainly relying on the Pfizer-BioNTech
COVID-19 vaccine and has administered much smaller
amounts of the Moderna and AstraZeneca shots.

There were also fewer than 200 cases in care homes last week
versus 1,250 three weeks ago while the relative number of deaths
in hospitals and homes are falling more rapidly than elsewhere
after Ireland suffered its deadliest wave to date last month.

"Very hearteningly, we think we are beginning to see strong
early evidence of a protective impact of vaccination on those
cohorts that are in the course of being vaccinated at present,"
Ireland's COVID-19 modelling chief Philip Nolan told a news
conference.

The government has said if vaccines arrive on schedule, 55%
to 60% of people will be fully vaccinated by the end of June.

Nolan added that even though the rate of decline in cases
has slowed in the last two weeks, Ireland continued to make
"significant progress" against all indicators of disease during
a lockdown that was extended into April this week.

The reproduction number - the number of people infected by
someone with COVID-19 - remained steady at 0.6 and 0.9, despite
the near dominance of the more infectious B1.1.7 variant first
detected in Britain.

The number of cases per 100,000 people in the past 14 days
has fallen to 226 from a high of over 1,500 less than six weeks
ago.

"Continue doing what you're doing. We've gone from a
situation where six, seven weeks ago we were the worst in the
world and through the actions of people, we are now in the top
10 in Europe," Deputy Chief Medical Officer Ronan Glynn said.
(Reporting by Padraic Halpin; editing by David Evans)

More News
20 May 2024 11:55

LONDON MARKET MIDDAY: Gold shines amid interest rate cut hopes

(Alliance News) - Stock prices in London got a boost at midday on Monday, as investors eye a key UK inflation reading later in the week, which is expected to show cooling prices.

Read more
20 May 2024 08:24

TOP NEWS: AstraZeneca plans to build manufacturing plant in Singapore

(Alliance News) - AstraZeneca PLC on Monday announced plans for a USD1.5 billion manufacturing facility in Singapore to produce antibody drug conjugates, treatments that deliver "highly potent cancer-killing agents".

Read more
20 May 2024 07:47

LONDON BRIEFING: Keywords would back GBP2.0 billion bid as EQT circles

(Alliance News) - London's FTSE 100 is called to open higher at the start of the week, while the pound climbed and gold hit another record high, with investors hopeful the Federal Reserve could soon cut US interest rates.

Read more
20 May 2024 07:22

AstraZeneca announces $1.5bn Singapore manufacturing facility

(Sharecast News) - AstraZeneca announced plans to construct a $1.5bn manufacturing facility in Singapore on Monday, dedicated to the production of antibody drug conjugates (ADCs).

Read more
16 May 2024 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.